AVGO vs ZENA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
ZENA exhibits severe financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price/Book ratio of -10.42, indicating negative shareholders' equity. While revenue growth is astronomical at 1225%, it has failed to translate into profitability, with operating margins at -110.49% and consistent, massive earnings misses. The current price of $2.09 trades at a significant premium to the growth-based intrinsic value of $0.28. Overall, the company shows signs of a high-growth venture that is burning cash rapidly without a clear path to sustainable earnings.
Compare Another Pair
Related Comparisons
AVGO vs ZENA: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and ZenaTech, Inc. (ZENA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.